Literature DB >> 12622955

[Coronary risk estimation in Spain using a calibrated Framingham function].

Jaume Marrugat1, Pascual Solanas, Ralph D'Agostino, Lisa Sullivan, José Ordovas, Ferran Cordón, Rafael Ramos, Joan Sala, Rafael Masià, Izabella Rohlfs, Roberto Elosua, William B Kannel.   

Abstract

INTRODUCTION AND
OBJECTIVES: The Framingham coronary heart disease (CHD) functions overestimate the risk of CHD in countries with a low incidence. Consequently, these functions should be calibrated for the purpose of primary prevention. Calibrated Framingham function charts of overall CHD risk for the Spanish population are presented. Patients and methods. The Framingham functions were calibrated by substituting the prevalence of CHD risk factors and incidence found in Framingham with the same values for Spain. The Framingham function that included high-density lipoprotein (HDL) cholesterol was used. The 10-year probability of developing a CHD event was estimated for several combinations of risk factors and HDL levels ranging from 35 to 59 mg/dl. Color-coded charts were prepared that show the exact probability of CHD corresponding to each combination of risk factors, shown in separate cells on the chart.
RESULTS: The event rate and prevalence of CHD risk factors differed considerably between Girona and Framingham. HDL < 35 mg/dL increased risk by approximately 50% and HDL > 60 mg/dL reduced it by 50%. The proportion of cells in which the 10-year probability of developing a CHD event was > 9% was 2.3 times higher and that of cells with a probability > 19% was 13 times lower in the chart calibrated for Spain than in the original Framingham charts.
CONCLUSIONS: The calibrated Framingham function may help to more accurately estimate the overall risk of CHD in the Spanish population for primary prevention purposes. The calibrated function should be validated, and the development of functions for the Spanish population should be promoted.

Entities:  

Mesh:

Year:  2003        PMID: 12622955     DOI: 10.1016/s0300-8932(03)76861-4

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  51 in total

Review 1.  [Evaluation of cardiovascular risk. What table to use?].

Authors:  A Maiques Galán
Journal:  Aten Primaria       Date:  2003-12       Impact factor: 1.137

2.  [Cardiovascular risk factors and Primary Care: evaluation and intervention].

Authors:  José María Lobos Bejarano; Carlos Brotons Cuixart
Journal:  Aten Primaria       Date:  2011-11-17       Impact factor: 1.137

3.  [Diabetes mellitus and cardiovascular risk. Is integrated therapy of type 2 diabetes and cardiovascular risk factors necessary?].

Authors:  Domingo Orozco Beltrán; Carlos de la Sen Fernández; Vicente Gil Guillén; Concepción Carratalá Munuera; Jorge Navarro Pérez
Journal:  Aten Primaria       Date:  2010-09       Impact factor: 1.137

4.  Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.

Authors:  John R Cook; Don Yin; Evo Alemao; Glenn Davies; Karl J Krobot; Enrico Veltri; Leslie Lipka; Xavier Badia
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  [Validity of the Framingham-REGICOR and DORICA coronary risk equations for a health centre's diabetic population].

Authors:  Lourdes Cañón Barroso; Eloísa Cruces Muro; Alejandra Fernández Gómez; Francisco Buitrago Ramírez
Journal:  Aten Primaria       Date:  2006-09       Impact factor: 1.137

6.  Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study.

Authors:  Lourdes Cañón Barroso; Eloísa Cruces Muro; Natalio Díaz Herrera; Gerardo Fernández Ochoa; Juan Ignacio Calvo Hueros; Francisco Buitrago
Journal:  Scand J Prim Health Care       Date:  2010-09-27       Impact factor: 2.581

7.  [Impact on cardiovascular health results of the introduction of the clinical governance contract into primary care in Tarragona].

Authors:  J Bladé-Creixenti; I Pascual-Moron; A Gómez-Sorribes; J Daniel-Diez; J L Piñol-Moreso
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

8.  Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study.

Authors:  Francisco Buitrago; Juan Ignacio Calvo-Hueros; Lourdes Cañón-Barroso; Gerónimo Pozuelos-Estrada; Luis Molina-Martínez; Manuel Espigares-Arroyo; Juan Antonio Galán-González; Francisco J Lillo-Bravo
Journal:  Ann Fam Med       Date:  2011 Sep-Oct       Impact factor: 5.166

Review 9.  Cardiovascular risk assessment scores for people with diabetes: a systematic review.

Authors:  P Chamnan; R K Simmons; S J Sharp; S J Griffin; N J Wareham
Journal:  Diabetologia       Date:  2009-07-24       Impact factor: 10.122

10.  Agreement between the SCORE and D'Agostino Scales for the classification of high cardiovascular risk in sedentary spanish patients.

Authors:  Manuel A Gómez-Marcos; Gonzalo Grandes; José A Iglesias-Valiente; Alvaro Sánchez; Imanol Montoya; Luis García-Ortiz
Journal:  Int J Environ Res Public Health       Date:  2009-11-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.